Intoplicine dimesylate
目录号: PL12354 纯度: ≥98%
CAS No. :133711-99-6
商品编号 规格 价格 会员价 是否有货 数量
PL12354-5mg 5mg ¥9890.91 请登录
PL12354-10mg 10mg ¥16072.73 请登录
PL12354-50mg 50mg 询价 询价
PL12354-100mg 100mg 询价 询价
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
Intoplicine dimesylate
英文名称
Intoplicine dimesylate
英文别名
11-{[3-(dimethylamino)propyl]amino}-8-methyl-7H-benzo[e]pyrido[4,3-b]indol-3-ol dimethanesulfonate (salt);7H-Benzo[e]pyrido[4,3-b]indole, 11-[3-(dimethylamino)propylamino]-3-hydroxy-8-methyl-, dimethanesulfonate;Intoplicine methasulfonate;Intoplicine dimesylate
Cas No.
133711-99-6
分子式
C21H23N4O.2[CH4O3S]
分子量
539.64
包装储存
4°C, sealed storage, away from moisture and light In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
产品详情
Intoplicine (RP 60475) dimesylate,一种 7H 苯并 [e] 吡啶并 [4,3-b] 吲哚系列的抗肿瘤衍生物,是一种 DNA 拓扑异构酶 I 和 II 抑制剂。Intoplicine dimesylate 与 DNA (KA = 2 x 105 /M) 强烈结合,从而增加线性 DNA 的长度。
生物活性
Intoplicine (RP 60475) dimesylate, an antitumor derivative in the 7H-benzo[e]pyrido[4,3-b]indole series, is a DNA topoisomerase I and II inhibitor. Intoplicine dimesylate strongly binds DNA (K A = 2 x 10 /M) and thereby increases the length of linear DNA.
性状
Solid
IC50 & Target[1][2]
Topoisomerase I Topoisomerase II
体外研究(In Vitro)
With 1-hour exposure to Intoplicine dimesylate at final concentrations of 2.5 micrograms/mL and 10.0 micrograms/mL, 26% and 54% of the assessable specimens shows positive in vitro responses, respectively.
With continuous exposure to Intoplicine dimesylate at concentrations of 0.25 micrograms/mL and 2.5 micrograms/mL, 16% and 71% of the assessable specimens showed positive responses, respectively.
Activity is seen against breast (71%), non-small-cell lung (69%), and ovarian (45%) cancer colony-forming units at a Intoplicine dimesylate concentration of 10.0 micrograms/mL after 1-hour exposure. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
At the highest non-toxic dose (HNTD) (6 mg/kg/injection, total dose, 36 mg/kg), intoplicine dimesylate shows highly active with a T/C of 0% and a corresponding total log cell kill of 3. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
4°C, sealed storage, away from moisture and light In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
ClinicalTrial
参考文献
[1]. Riou JF, et al. Intoplicine (RP 60475) and its derivatives, a new class of antitumor agents inhibiting both topoisomerase I and II activities. Cancer Res. 1993;53(24):5987-5993.
[2]. Eckardt JR, et al. Activity of intoplicine (RP60475), a new DNA topoisomerase I and II inhibitor, against human tumor colony-forming units in vitro. J Natl Cancer Inst. 1994;86(1):30-33.
溶解度数据
In Vitro: DMSO : 115 mg/mL (212.71 mM; Need ultrasonic)H2O : 100 mg/mL (184.96 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2